Loading...
Loading...
Application UK00801199136 · Registered
| Application Number | UK00801199136 |
| Status | Registered |
| Owner | Smiths Detection Inc. |
| Filed | 2014-02-20 |
| Registered | 2015-02-24 |
| Renewal Due | 2034-02-20 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. TARGET-ID is currently a registered UK trademark, with renewal due on 2034-02-20. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Hand-held device comprised of chemical and heat sensors for the detection of narcotics and other chemicals.
'TARGET-ID' is a registered trademark on the UK IPO register, owned by Smiths Detection Inc.. The application (UK00801199136) was filed on 20 February 2014 and registered on 24 February 2015. The registration is set to expire on 20 February 2034.
This mark is recorded under Class 9 (scientific, electrical & IT apparatus).
The trademark is represented by Julia Anne Matheson Finnegan Henderson Farabow Garrett & Dunner, LLP.
UK trademark UK00801199136 for the mark 'TARGET-ID' in Class 9 is recorded on the UK IPO register as owned by Smiths Detection Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00801199136 for the mark 'TARGET-ID' as registered.
UK trademark UK00801199136 for the mark 'TARGET-ID' is registered in Class 9 (scientific, electrical & IT apparatus). The filed specification reads: Class 9: Hand-held device comprised of chemical and heat sensors for the detection of narcotics and other chemicals.
UK trademark UK00801199136 for the mark 'TARGET-ID' was filed at the UK IPO on 20 February 2014 and registered on 24 February 2015.
UK trademark UK00801199136 for the mark 'TARGET-ID' is currently recorded as valid until 20 February 2034, at which point it will need to be renewed with the UK IPO to remain in force.
Julia Anne Matheson Finnegan Henderson Farabow Garrett & Dunner, LLP is listed as the attorney / representative of record for UK trademark UK00801199136 for the mark 'TARGET-ID' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "TARGET-ID" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| TARGET-IDSame applicant | 86171302 | 702 | 2014-01-21 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SOFTWARE AS A SERVICE (SAAS) AND PLATFORM AS A SERVICE (PAAS) FEATURING ARTIFICIAL INTELLIGENCE SOFTWARE AND CLOUD-BASED PLATFORMS FOR USE IN MEDICAL DIAGNOSTICS, HEALTHCARE DATA ANALYSIS, DISEASE DETECTION, AND CLINICAL DECISION SUPPORT; PROVIDING TEMPORARY USE OF NON-DOWNLOADABLE SOFTWARE FOR ANALYZING GENOMIC, PROTEOMIC, METABOLOMIC, TRANSCRIPTOMIC, AND MULTI-OMICS DATA TO SUPPORT PRECISION MEDICINE AND PERSONALIZED HEALTHCARE; PROVIDING ONLINE NON-DOWNLOADABLE SOFTWARE USING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE FOR BIOINFORMATICS, BIOLOGICAL DATA INTERPRETATION, BIOMARKER DISCOVERY, DRUG TARGET IDENTIFICATION, AND DRUG DISCOVERY; SCIENTIFIC AND TECHNOLOGICAL RESEARCH SERVICES IN THE FIELDS OF BIOTECHNOLOGY, LIFE SCIENCES, HEALTHCARE, AND ARTIFICIAL INTELLIGENCE, NAMELY, RESEARCH AND DEVELOPMENT OF DIAGNOSTIC METHODS, THERAPEUTIC STRATEGIES, AND BIOPHARMACEUTICAL TECHNOLOGIES; DESIGN, DEVELOPMENT, AND HOSTING OF CLOUD-BASED PLATFORMS FOR BIOMEDICAL DATA INTEGRATION, COMPUTATIONAL BIOLOGY, PREDICTIVE ANALYTICS, AND CLINICAL RESEARCH COLLABORATION. | 99443174 | 622 | 2025-10-14 |
| IDRYFIRE LASER TARGET SYSTEM | 90162240 | 602 | 2020-09-06 |
| PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS | 79266965 | 602 | 2019-05-22 |
| IDNAFY FIND THE MUTATION · TARGET THE THERAPY | 87222134 | 710 | 2016-11-01 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| TARGET-IDSame applicant | 1617933 | protected | 2014-04-17 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.